Treatment of HIV-related inflammatory cerebral cryptococcoma with adalimumab

Clinical Infectious Diseases

Volumn 50, Issue 2, 2010, Pages

  Sitapati, Amy M ^a   Kao, Cynthia L ^a   Cachay, Edward R ^a   Masoumi, Homeyra ^b   Wallis, Robert S ^c   Christopher Mathews, W ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AMPHOTERICIN B LIPID COMPLEX; CORTICOSTEROID; DEXAMETHASONE; EFAVIRENZ; EMTRICITABINE; ETIRACETAM; FLUCONAZOLE; FLUCYTOSINE; GLUCOSE; ISONIAZID; LAMIVUDINE; PROTEIN; PYRIDOXINE; TENOFOVIR; VALPROATE SEMISODIUM; VIRUS RNA; ZIDOVUDINE;

ACID FAST BACTERIUM; ADD ON THERAPY; ADULT; ARTICLE; BRAIN VENTRICLE PERITONEUM SHUNT; CASE REPORT; CD4+ T LYMPHOCYTE; CEREBROSPINAL FLUID ANALYSIS; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CRYPTOCOCCAL MENINGITIS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG WITHDRAWAL; EDEMA; ERYTHROCYTE COUNT; GLUCOSE BLOOD LEVEL; GRAND MAL SEIZURE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INFLAMMATORY CEREBRAL CRYPTOCOCCOMA; INTRACRANIAL HYPERTENSION; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE ATROPHY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RNA VIRUS; SEIZURE; STEREOTACTIC BIOPSY; TREATMENT DURATION; TUBERCULOSIS;

ADULT; ANTIBODIES, MONOCLONAL; HIV INFECTIONS; HUMANS; MALE; MENINGITIS, CRYPTOCOCCAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 73649126235     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/649553     Document Type: Article

References (14)

1. Shelburne SA, Darcount J, White CA, et al. The role of immune reconstitution inflammatory syndrome in AIDS related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. Clin Infect Dis 2005;40:1049-1052
2. 2. Bicanic T, Harrison T, Niepieklo A, Dyakopu N, Meintjes G. Symptomatic relapse of HIV-associated cryptococal meningitis after initial fluconazole monotherapy: the role of fluconazole resistance and immune reconstitution. Clin Infect Dis 2006;43:1069-1073 (Pubitemid 44631110)
3. Powderly WG. Cryptococcal meningitis and AIDS. Clin Infect Dis 1993;17:837-842
4. 4. Sanchez-Portocarrero J, Perez-Cecilia E. Intracerebral mass lesions in pateints wtih human immunodeficiency virus infection and cryptococcal meningitis. Diagn Microbiol Infect Dis 1997;29:193-198 (Pubitemid 27519528)
5. 5. Cheg YC, Ling JF, Chang FC, et al. Radiological manifestations of cryptococcal infection in central nervous system. J Chin Med Assoc 2003;66:19-26. (Pubitemid 37265495)
6. 6. Lesho E. Evidence base for using corticosteroids to treat HIV-associated immune reconstitution syndrome. Expert Rev Anti Infect Ther 2006;4: 469-478 (Pubitemid 43905468)
7. Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H. Guidelines for prevention and treatment of opportunistic infections in HIVinfected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009; 58(RR-4):1-207.
8. Blackmore TK, Manning L, Taylor WJ, Wallis RS. Therapeutic use of infliximab in tuberculosis to control severe paradoxical reaction of the brain and lymph nodes. Clin Infect Dis 2008;47:83-85
9. 9. Wallis R, Kyambadde P, Johnson J, et al. A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV1-associated tuberculosis. AIDS 2004;18:257-264 (Pubitemid 38253448)
10. Huffnagle GB, Toews GB, Burdick MD, et al. Afferent phase production of TNF-α is required for the development of protective T cell immunity to C. neoformans. J Immunol 1996;157:4529-4536
11. 11. Scallon B, Cai A, Solowski N, et al. Binding and functional compari-sons of two types of tumor factor antagonists. J Pharmacol Exp Ther 2002;301:418-426 (Pubitemid 34429950)
12. Siddiqui AA, Brouwer AE, Wuthiekanun V, et al. INF-γ at the site of infection determines rate of clearance of infection in cryptococcal meningitis. J Immunol 2005;174:1746-1750
13. Bicanic T, Meintjes G, Rebe K, et al. Immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis: a prospective study. J Acquir Immune Defic Syndr 2009;51:130-134
14. Horcajada JP, Pena JL, Martinez-Taboada VM, et al. Invasive cryptococcosis and adalimumab treatment. Emerg Infect Dis 2007;13:953-955